Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 6,880 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were bought at an average price of $5.05 per share, for a total transaction of $34,744.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, November 8th, Levin Capital Strategies, L.P. purchased 54,900 shares of Fluidigm Corporation stock. The shares were bought at an average price of $5.26 per share, for a total transaction of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. purchased 4,227 shares of Fluidigm Corporation stock. The shares were bought at an average price of $5.42 per share, for a total transaction of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. purchased 22,363 shares of Fluidigm Corporation stock. The shares were bought at an average price of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The shares were bought at an average price of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. purchased 144,200 shares of Fluidigm Corporation stock. The shares were bought at an average price of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. purchased 50,000 shares of Fluidigm Corporation stock. The shares were bought at an average price of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm Corporation stock. The shares were bought at an average price of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The shares were bought at an average price of $5.25 per share, for a total transaction of $315,000.00.

Shares of Fluidigm Corporation (NASDAQ:FLDM) traded up $0.23 during trading on Thursday, reaching $5.60. The company’s stock had a trading volume of 238,300 shares, compared to its average volume of 258,754. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02. Fluidigm Corporation has a 12 month low of $2.52 and a 12 month high of $8.69.

TRADEMARK VIOLATION NOTICE: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/11/23/levin-capital-strategies-l-p-buys-6880-shares-of-fluidigm-corporation-fldm-stock.html.

Separately, ValuEngine lowered Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th.

A number of institutional investors have recently made changes to their positions in FLDM. Neuberger Berman Group LLC grew its position in Fluidigm Corporation by 181.6% in the 3rd quarter. Neuberger Berman Group LLC now owns 5,213,481 shares of the medical research company’s stock valued at $26,276,000 after acquiring an additional 3,362,100 shares during the last quarter. Russell Investments Group Ltd. grew its position in Fluidigm Corporation by 46.8% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,447,491 shares of the medical research company’s stock valued at $17,370,000 after acquiring an additional 1,099,072 shares during the last quarter. Bank of New York Mellon Corp grew its position in Fluidigm Corporation by 70.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 370,427 shares of the medical research company’s stock valued at $1,867,000 after acquiring an additional 152,588 shares during the last quarter. State Street Corp grew its position in Fluidigm Corporation by 6.2% in the 2nd quarter. State Street Corp now owns 499,524 shares of the medical research company’s stock valued at $2,017,000 after acquiring an additional 29,110 shares during the last quarter. Finally, Northern Trust Corp grew its position in Fluidigm Corporation by 7.2% in the 2nd quarter. Northern Trust Corp now owns 406,560 shares of the medical research company’s stock valued at $1,642,000 after acquiring an additional 27,400 shares during the last quarter. 78.65% of the stock is currently owned by institutional investors.

Fluidigm Corporation Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Stock Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related stocks with our FREE daily email newsletter.